Works matching IS 2160763X AND DT 2022 AND VI 11 AND IP 4


Results: 13
    1

    Issue Information.

    Published in:
    Clinical Pharmacology in Drug Development, 2022, v. 11, n. 4, p. 415, doi. 10.1002/cpdd.826
    Publication type:
    Article
    2
    3
    4
    5
    6

    Lack of Electrocardiographic Effects of Deucravacitinib in Healthy Subjects.

    Published in:
    Clinical Pharmacology in Drug Development, 2022, v. 11, n. 4, p. 442, doi. 10.1002/cpdd.1056
    By:
    • Chimalakonda, Anjaneya;
    • Singhal, Shalabh;
    • Darbenzio, Raymond;
    • Dockens, Randy;
    • Marchisin, David;
    • Banerjee, Subhashis;
    • Girgis, Ihab G.;
    • Throup, John;
    • He, Bing;
    • Aras, Urvi;
    • Murthy, Bindu
    Publication type:
    Article
    7
    8
    9
    10
    11

    Clinical Pharmacokinetics and Safety of a 10% Aminolevulinic Acid Hydrochloride Nanoemulsion Gel (BF‐200 ALA) in Photodynamic Therapy of Patients Extensively Affected With Actinic Keratosis: Results of 2 Maximal Usage Pharmacokinetic Trials.

    Published in:
    Clinical Pharmacology in Drug Development, 2022, v. 11, n. 4, p. 535, doi. 10.1002/cpdd.1023
    By:
    • Novak, Ben;
    • DuBois, Janet;
    • Chahrour, Osama;
    • Papusha, Tamara;
    • Hirt, Stefan;
    • Philippi, Thomas;
    • Zogel, Corinna;
    • Osenberg, Katharina;
    • Schmitz, Beate;
    • Lübbert, Hermann
    Publication type:
    Article
    12
    13